Abstract:This review particularly analyzes the latest advances in the application of self‐assembled nano drug delivery platforms in combined antitumor therapies mediated by chemotherapy, phototherapy, radiotherapy, sonodynamic therapy, and immunotherapy, thereby providing innovative research insights for further optimization and expansion of self‐assembled nano drug delivery systems in the clinical translation and development of antitumor combined therapy. The rapid development of self‐assembly technology during the past few decades has effectively addressed plenty of the issues associated with carrier‐based drug delivery systems, such as low loading efficiency, complex fabrication processes, and inherent toxicity of carriers. The integration of nanoscale delivery systems with self‐assembly techniques has enabled efficient and targeted self‐administration of drugs, enhanced bioavailability, prolonged circulation time, and controllable drug release. Concurrently, the limitations of single‐mode cancer treatment, including low bioavailability, poor therapeutic outcomes, and significant side effects, have highlighted the urgent need for multimodal combined antitumor therapies. Set against the backdrop of multimodal cancer therapy, this review summarizes the research progress and applications of a large number of self‐assembled drug delivery platforms, including natural small molecule self‐assembled, carrier‐free self‐assembled, amphiphilic polymer‐based self‐assembled, peptide‐based self‐assembled, and metal‐based self‐assembled nano drug delivery systems. This review particularly analyzes the latest advances in the application of self‐assembled nano drug delivery platforms in combined antitumor therapies mediated by chemotherapy, phototherapy, radiotherapy, sonodynamic therapy, and immunotherapy, providing innovative research insights for further optimization and expansion of self‐assembled nano drug delivery systems in the clinical translation and development of antitumor combined therapy.

In situ self-assembly for cancer therapy and imaging

Self-assembled polymer nanostructures for delivery of anticancer therapeutics

In Situ Stimulus-responsive Self-assembled Nanomaterials for Drug Delivery and Disease Treatment

Tumor microenvironment-triggered intratumoral in situ construction of theranostic supramolecular self-assembly

Self-Assembled Hybrid Nanostructures: Versatile Multifunctional Nanoplatforms for Cancer Diagnosis and Therapy

Cancer‐Selective Supramolecular Chemotherapy by Disassembly‐Assembly Approach

In Situ Supramolecular Self-Assembly for Alleviating Multidrug Resistance in Cancer

Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications

Tumor-Specific Formation Of Enzyme-Instructed Supramolecular Self-Assemblies As Cancer Theranostics

Tumor-responsive Dynamic Nanoassemblies for Targeted Imaging, Therapy and Microenvironment Manipulation.

Self-Assembly of Small Organic Molecules into Luminophores for Cancer Theranostic Applications

How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?

Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy

Engineering Self-Assembled Nanomedicines Composed of Clinically Approved Medicines for Enhanced Tumor Nanotherapy

Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery

Supramolecular nanofibers with superior anti-angiogenesis and antitumor properties by enzyme-instructed self-assembly (EISA)

Self‐Assembled Nanoparticles as Cancer Therapeutic Agents

Self-propelled assembly of nanoparticles with self-catalytic regulation for tumour-specific imaging and therapy

Application of molecular dynamics simulation in self-assembled cancer nanomedicine

In vivo metallophilic self-assembly of a light-activated anticancer drug

Metal Ion-Based Supramolecular Self-Assembly for Cancer Theranostics